In-Vitro & Cell-Based Assay Services
Our in-vitro and cell-based assay services provide critical biological, pharmacokinetic, and safety insights during early discovery and preclinical development. All experimental work is executed through accredited partner laboratories, ensuring adherence to international quality standards and regulatory expectations.
These services support evidence-based decision-making across drug discovery, biologics development, and natural product research.
Discovery & Screening Capabilities
We offer a comprehensive portfolio of discovery and screening assays to evaluate compound activity, biological relevance, and functional mechanisms.-
Reporter gene assays
-
Cytotoxicity and viability assays
-
Mechanism of action assays
-
Custom assay development
Reporter Gene Assays
Reporter gene assays are used to assess pathway modulation, receptor activation, and transcriptional responses, enabling precise target validation and early screening.
Cytotoxicity & Cell Viability Testing
Our cytotoxicity and viability assays help determine dose-dependent cellular effects, supporting early safety profiling and candidate prioritization.
Mechanism of Action Studies
We conduct mechanism of action assays to define biological pathways, molecular targets, and functional outcomes, supporting differentiation and translational relevance.
Custom Assay Development
We support custom assay development for specialized targets or non-standard endpoints, ensuring scientific relevance and reproducibility.Our cytotoxicity and viability assays help determine dose-dependent cellular effects, supporting early safety profiling and candidate prioritization.
ADME & Toxicology Screening Services
Our ADME and toxicology screening offerings generate essential data on metabolism, transport, and exposure-related risk.-
CYP Inhibition & Induction
-
Transporter Interaction Studies
-
In-Vitro–In-Vivo Correlation (IVIVC)
CYP Inhibition & Induction
We perform CYP inhibition and induction studies in line with FDA guidance, supporting early drug–drug interaction risk assessment.
Transporter Interaction Studies
Our transporter studies evaluate interactions with P-gp, BCRP, and OATP, aligned with FDA and EMA recommendations, to inform absorption and clearance profiles.
In-Vitro–In-Vivo Correlation (IVIVC)
IVIVC studies integrate laboratory findings with in-vivo outcomes to improve predictability of pharmacokinetics and clinical performance.
Why Choose Our In-Vitro & Cell-Based Assay Offering?
Studies executed via accredited partner laboratories
Regulatory-aligned ADME, toxicology, and genotoxicity panels
Strong focus on mechanism-driven discovery
High-quality, decision-ready datasets